Abstract | OBJECTIVE: In 1991, a randomized study was published and demonstrated that use of nonsurgical therapy (chemoradiation) provided similar survival to total laryngectomy (the gold standard) for patients with advanced-stage laryngeal cancer. The purpose of this study was to assess how treatment of advanced laryngeal cancer was influenced by such developments in non-surgical therapy. STUDY DESIGN: Patterns of care study using National Cancer Database (1985-2001). RESULTS: The percentage of advanced-stage patients treated with chemoradiation increased from 8.3% to 20.8% while the proportion treated with radiation alone decreased from 38.9% to 23.0%. Use of chemoradiation increased at a significantly faster rate after the 1991 publication at both community cancer centers and teaching research facilities. The use of total laryngectomy decreased slightly during this period. CONCLUSIONS: The use of chemoradiation increased after the 1991 publication. It was impossible to determine from the NCDB whether additional patients who could benefit from chemo-RT were not offered or did not complete this treatment option. We recommend that treatment recommendations discussed at tumor boards be recorded in cancer registries.
|
Authors | Amy Y Chen, Nicole Schrag, Yongping Hao, W Dana Flanders, James Kepner, Andrew Stewart, Elizabeth Ward |
Journal | Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
(Otolaryngol Head Neck Surg)
Vol. 135
Issue 6
Pg. 831-7
(Dec 2006)
ISSN: 0194-5998 [Print] England |
PMID | 17141069
(Publication Type: Comparative Study, Journal Article, Meta-Analysis)
|
Chemical References |
|
Topics |
- Aged
- Antineoplastic Agents
(therapeutic use)
- Cancer Care Facilities
(statistics & numerical data)
- Combined Modality Therapy
- Female
- Hospitals, Community
(statistics & numerical data)
- Hospitals, Teaching
(statistics & numerical data)
- Humans
- Laryngeal Neoplasms
(drug therapy, radiotherapy)
- Laryngectomy
(statistics & numerical data, trends)
- Male
- Medical Oncology
(trends)
- Middle Aged
- United States
|